Cointime

Uygulamayı indirmek için QR kodu tarayın
iOS & Android

Alnylam Pharmaceuticals

company
Exit Type
IPO
Exit Date
Jun 4, 2004

Exit parties in this round

Partner Fund Round Return Amount Return Multiplier
Merck Series Unknown — — Detail
Takeda Seed — — Detail
Regeneron Series B — — Detail
ARCH Venture Partners Series A — — Detail